Polymorphic Ala-allele carriers at residue 1170 of HER2 associated with Parkinson's disease

Journal of the Neurological Sciences

Volumn 325, Issue 1-2, 2013, Pages 115-119

  Wang, Vinchi ^a,b   Chuang, Tzu Chao ^c   Kao, Ming Ching ^d,e   Shan, Din E ^f,g   Soong, Bing Wen ^f,g   Shieh, Tzong Ming ^d  

^a CARDINAL TIEN HOSPITAL   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^c TAMKANG UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

^e NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^f TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^g NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Ala carrier; HER2; Parkinson's disease; Polymorphism

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ADULT; AGED; ALLELE; ARTICLE; CANCER RESEARCH; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GENE FREQUENCY; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NERVE CELL DIFFERENTIATION; NERVE INJURY; NUCLEOTIDE SEQUENCE; PARKINSON DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; ALANINE; ALLELES; CELL SURVIVAL; DOPAMINE; FEMALE; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; POLYMORPHISM, GENETIC; RECEPTOR, ERBB-2;

EID: 84872974014     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2012.12.017     Document Type: Article

References (41)

1. Z. Cai, H. Zhang, J. Liu, A. Berezov, R. Murali, and Q. Wang Targeting erbB receptors Semin Cell Dev Biol 21 2010 961 966
2. S. Shah, and B. Chen Testing for HER2 in breast cancer: a continuing evolution Pathol Res Int 2011 2010 903202
3. M.F. Hou, S.B. Lin, S.S. Yuan, S.M. Tsai, S.H. Wu, and F. Ou-Yang The clinical significance between activation of nuclear factor kappa B transcription factor and overexpression of HER-2/neu oncoprotein in Taiwanese patients with breast cancer Clin Chim Acta 334 2003 137 144 (Pubitemid 36836067)
4. J.W. Li, T.C. Chuang, A.H. Yang, C.K. Hsu, and M.C. Kao Clinicopathological relevance of HER2/neu and a related gene-protein cubic regression correlation in colorectal adenocarcinomas in Taiwan Int J Oncol 26 2005 933 943
5. D.G. Cox, S.E. Hankinson, and D.J. Hunter The erbB2/HER2/neu receptor polymorphism Ile655Val and breast cancer risk Pharmacogenet Genomics 15 2005 447 450 (Pubitemid 41017592)
6. W. Tao, C. Wang, R. Han, and H. Jiang HER2 codon 655 polymorphism and breast cancer risk: a meta-analysis Breast Cancer Res Treat 114 2009 371 376
7. B. Frank, K. Hemminki, M. Wirtenberger, J.L. Bermejo, P. Bugert, and R. Klaes The rare ERBB2 variant Ile654Val is associated with an increased familial breast cancer risk Carcinogenesis 26 2005 643 647 (Pubitemid 41214155)
8. P.R. Benusiglio, F. Lesueur, C. Luccarini, D.M. Conroy, M. Shah, and D.F. Easton Common ERBB2 polymorphisms and risk of breast cancer in a white British population: a case-control study Breast Cancer Res 7 2005 R204 R209
9. W. Han, D. Kang, J.E. Lee, I.A. Park, J.Y. Choi, and K.M. Lee A haplotype analysis of HER-2 gene polymorphisms: association with breast cancer risk, HER-2 protein expression in the tumor, and disease recurrence in Korea Clin Cancer Res 11 2005 4775 4778
10. A.B. Heimberger, R. Hlatky, D. Suki, D. Yang, J. Weinberg, and M. Gilbert Prognostic effect of epidermal growth factor receptor and EGFRvIII in glioblastoma multiforme patients Clin Cancer Res 11 2005 1462 1466 (Pubitemid 40315227)
11. G. López-Bendito, A. Cautinat, J.A. Sánchez, F. Bielle, N. Flames, and A.N. Garratt Tangential neuronal migration controls axon guidance: a role for neuregulin-1 in thalamocortical axon navigation Cell 125 2006 127 142
12. K.M. Gerecke, J.M. Wyss, and S.L. Carroll Neuregulin-1β induces neurite extension and arborization in cultured hippocampal neurons Mol Cell Neurosci 27 2004 379 393 (Pubitemid 39539993)
13. C. Taveggia, G. Zanazzi, A. Petrylak, H. Yano, J. Rosenbluth, and S. Einheber Neuregulin-1 type III determines the ensheathment fate of axons Neuron 47 2005 681 694 (Pubitemid 41208007)
14. L. Fallon, C.M. Belanger, A.T. Corera, M. Kontogiannea, E. Regan-Klapisz, and F. Moreau A regulated interaction with the UIM protein Eps15 implicates parkin in EGF receptor trafficking and PI(3)K-Akt signalling Nat Cell Biol 8 2006 834 842 (Pubitemid 44151586)
15. G.C. O'Keeffe, P. Tyers, D. Aarsland, J.W. Dalley, R.A. Barker, and M.A. Caldwell Dopamine-induced proliferation of adult neural precursor cells in the mammalian subventricular zone is mediated through EGF Proc Natl Acad Sci USA 106 2009 8754 8759
16. Y.R. Wu, C.M. Chen, C.Y. Chao, L.S. Ro, R.K. Lyu, and K.H. Chang Glucocerebrosidase gene mutation is a risk factor for early onset of Parkinson disease among Taiwanese J Neurol Neurosurg Psychiatry 78 2007 977 979
17. R.M. Wu, C.W. Cheng, K.H. Chen, S.L. Lu, D.E. Shan, and Y.F. Ho The COMT L allele modifies the association between MAOB polymorphism and PD in Taiwanese Neurology 56 2001 375 382 (Pubitemid 32144150)
18. R. Kaiser, A. Hofer, A. Grapengiesser, T. Gasser, A. Kupsch, and I. Roots L-dopa-induced adverse effects in PD and dopamine transporter gene polymorphism Neurology 60 2003 1750 1755 (Pubitemid 36737068)
19. D.G. Healy, P.M. Abou-Sleiman, T. Ozawa, A.J. Lees, K. Bhatia, and K.R. Ahmadi A functional polymorphism regulating dopamine β-hydroxylase influences against Parkinson's disease Ann Neurol 55 2004 443 446 (Pubitemid 38269600)
20. V. Wang, T.C. Chuang, B.W. Soong, D.E. Shan, and M.C. Kao Octarepeat changes of prion protein in Parkinson's disease Parkinsonism Relat Disord 15 2009 53 58
21. Y. Iwakura, Y.S. Piao, M. Mizuno, N. Takei, A. Kakita, and H. Takahashi Influences of dopaminergic lesion on epidermal growth factor-ErbB signals in Parkinson's disease and its model: neurotrophic implication in nigrostriatal neurons J Neurochem 93 2005 974 983 (Pubitemid 40695756)
22. B. Wagner, A. Natarajan, S. Grünaug, R. Kroismayr, E.F. Wagner, and M. Sibilia Neuronal survival depends on EGFR signaling in cortical but not midbrain astrocytes EMBO J 25 2006 752 762 (Pubitemid 43292437)
23. Z. Ahmed, S.J. Jacques, M. Berry, and A. Logan Epidermal growth factor receptor inhibitors promote CNS axon growth through off-target effects on glia Neurobiol Dis 36 2009 142 150
24. A.J. Hughes, S.E. Daniel, L. Kilford, and A.J. Lees Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases J Neurol Neurosurg Psychiatry 55 1992 181 184
25. V.C. Wang, J.W. Li, J.H. Suen, T.C. Chuang, and M.C. Kao Ile/Ile homozygosity at codon 655 of HER2 in schwannoma Acta Neurol Taiwan 20 2011 243 248
26. J. Papewalis, A.Y. Nikitin, and M.F. Rajewsky G to A polymorphism at amino acid codon 655 of the human erbB-2/HER2 gene Nucleic Acid Res 19 1991 5452
27. W. Le, D. Rowe, W. Xie, I. Ortiz, Y. He, and S.H. Appel Microglial activation and dopaminergic cell injury: an in vitro model relevant to Parkinson's disease J Neurosci 21 2001 8447 8455 (Pubitemid 33051443)
28. M.S. Yoo, H.S. Chun, J.J. Son, L.A. DeGiorgio, D.J. Kim, and C. Peng Oxidative stress regulated genes in nigral dopaminergic neuronal cells: correlation with the known pathology in Parkinson's disease Brain Res Mol Brain Res 110 2003 76 84 (Pubitemid 36165044)
29. J.J. Gagne, and M.C. Power Anti-inflammatory drugs and risk of Parkinson disease: a meta-analysis Neurology 74 2010 995 1002
30. C.F. Orr, D.B. Rowe, Y. Mizuno, H. Mori, and G.M. Halliday A possible role for humoral immunity in the pathogenesis of Parkinson's disease Brain 128 2005 2665 2674 (Pubitemid 41552950)
31. V. Wang, L.G. Chia, D.R. Ni, L.J. Cheng, Y.P. Ho, and F.C. Cheng Effects of the combined treatment of naloxone and indomethacin on catecholamines and behavior after intranigral lipopolysaccharide injection Neurochem Res 29 2004 341 346 (Pubitemid 38223014)
32. N. Ahmed, V.S. Salsman, Y. Kew, D. Shaffer, S. Powell, and Y.J. Zhang HER2-specific T cells target primary glioblastoma stem cells and induce regression of autologous experimental tumors Clin Cancer Res 16 2010 474 485
33. Y.K. Kwon, A. Bhattacharyya, J.A. Alberta, W.V. Giannobile, K. Cheon, and C.D. Stiles Activation of ErbB2 during wallerian degeneration of sciatic nerve J Neurosci 17 1997 8293 8299 (Pubitemid 27461053)
34. Z. Xu, and B.D. Ford Upregulation of erbB receptors in rat brain after middle cerebral arterial occlusion Neurosci Lett 375 2005 181 186 (Pubitemid 40202949)
35. R. Massa, C. Palumbo, T. Cavallaro, M.B. Panico, R. Bei, and C. Terracciano Overexpression of ErbB2 and ErbB3 receptors in Schwann cells of patients with Charcot-Marie-tooth disease type 1A Muscle Nerve 33 2006 342 349
36. S. Tommasi, V. Fedele, R. Lacalamita, M. Bruno, F. Schittulli, and D. Ginzinger 655Val and 1170Pro ERBB2 SNPs in familial breast cancer risk and BRCA1 alterations Cell Oncol 29 2007 241 248 (Pubitemid 46855704)
37. K.S. Mineev, E.V. Bocharov, Y.E. Pustovalova, O.V. Bocharova, V.V. Chupin, and A.S. Arseniev Spatial structure of the transmembrane domain heterodimer of ErbB1 and ErbB2 receptor tyrosine kinases J Mol Biol 400 2010 231 243
38. R.W. Mahley, K.H. Weisgraber, and Y. Huang Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease Proc Natl Acad Sci USA 103 2006 5644 5651
39. F. Shi, S.E. Telesco, Y. Liu, R. Radhakrishnan, and M.A. Lemmon ErbB3/HER3 intracellular domain is competent to bind ATP and catalyze autophosphorylation Proc Natl Acad Sci USA 107 2010 7692 7697
40. R. Inzelberg, O.S. Cohen, J. Aharon-Peretz, I. Schlesinger, R. Gershoni-Baruch, and R. Djaldetti The LRRK2 G2019S mutation is associated with Parkinson disease and concomitant non-skin cancers Neurology 78 2012 781 786
41. H.G. Choi, J. Zhang, X. Deng, J.M. Hatcher, M.P. Patricelli, and Z. Zhao Brain penetrant LRRK2 inhibitor ACS Med Chem Lett 3 2012 658 662